Printer Friendly

Articles from Biotech Business (November 1, 2000)

1-6 out of 6 article(s)
Title Author Type Words
BOSTON PROBES GETS PATENT FOR PNA PROBE TECHNOLOGY. 334
COPERNICUS GETS PHASE I SBIR GRANT FOR TOPICAL VACCINES. 500
CORIXA GETS 2.3 MILLION GRANT FOR TUBERCULOSIS VACCINE. 471
EUKARION GETS PATENT FOR TOPICAL USE OF SCS COMPOUNDS. 509
INTEGRA GETS GRANT TO DEVELOP RGD TECHNOLOGY. 660
IVAX GETS FINAL APPROVAL FOR GENERIC HYPERTENSION TABLETS. 147

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |